Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Will the Real PepsiCo Please Identify Itself?

By Chris Markoch, InvestorPlace Contributor

Pepsi stock has made back most of its pandemic losses. But the company's push into new markets may be holding back its efforts to reclaim all-time highs.

Dividend Darling Energy Transfer Stock Faces a Trilogy of Trouble

By Chris Markoch, InvestorPlace Contributor

Energy Transfer is drawing the attention of speculative investors. However, ET stock faces three key issues that are ample reason for the low price.

Don’t Be Deceived: There’s No Reason to Speculate on Ocugen

By Chris Markoch, InvestorPlace Contributor

Ocugen continues to conduct at-the-market offerings to raise capital. But with a distant payoff, OCGN stock offers too much risk and not enough reward.

iBio Takes Swings, But Hasn’t Found a Pitch It Can Hit

By Chris Markoch, InvestorPlace Contributor

There has been a lot of noise surrounding IBIO stock. But investors need that noise to turn into actionable news to reverse the stock's trend.

FuelCell Investors May Be in for a Very Scary Halloween

By Chris Markoch, InvestorPlace Contributor

FCEL stock has been dropping after a poor earnings report. Unfortunately, FuelCell doesn't have any immediate catalyts in place to reverse its fortunes.

Load More